Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy.

Saved in:
Bibliographic Details
Title: Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy.
Authors: Lai, Zhiheng1,2 (AUTHOR), Pang, Yanyang1 (AUTHOR), Zhou, Yujing3 (AUTHOR), Chen, Leiyuan1 (AUTHOR), Zheng, Kai4,5 (AUTHOR), Yuan, Shiguo4,5 (AUTHOR) ysg@smu.edu.cn, Wang, Wu1 (AUTHOR) lxd8860@163.com
Source: BMC Cancer. 3/6/2025, Vol. 25 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-025-13831-8